Re "Why Lutetium-177-PSMA treatment s... - Advanced Prostate...

Advanced Prostate Cancer

23,770 members29,063 posts

Re "Why Lutetium-177-PSMA treatment sometimes may not help, and may even harm" article

podsart profile image
10 Replies

In this article, the following is stated

• In men with low PSMA, the PSA50 was 52% for Lu177PSMA vs 32% for cabazitaxel

Why with a low PSMA would be higher [ PSA50 ] at 52% vs 32% for Jevtana?

Written by
podsart profile image
podsart
To view profiles and participate in discussions please or .
Read more about...
10 Replies
Tall_Allen profile image
Tall_Allen

Pluvicto had much greater PSA50 in men with high PSMA. There was no difference in survival, however.

• In men with high PSMA, the PSA50 was 91% for Lu177PSMA vs 47% for cabazitaxel

• Among men with high PSMA, the odds ratio of responding to Lu177PSMA was 12.2 vs 2.2 for cabazitaxel

• In men with low PSMA, the PSA50 was 52% for Lu177PSMA vs 32% for cabazitaxel

• In men with high FDG, the PSA50 was 57% for Lu177PSMA vs 20% for cabazitaxel

• Among men with a high FDG, the odds ratio of any response to either treatment was 0.44

• In men with low FDG, the PSA50 was 70% for Lu177PSMA vs 44% for cabazitaxel

OuttaTime profile image
OuttaTime in reply toTall_Allen

I don’t understand how you have this worded psa50? What does greater psa50 mean greater than psa 50? Or the psa50 was 57% for Lu-177 vs 20% cabazitaxel? I don’t understand?

podsart profile image
podsart in reply toOuttaTime

Not sure, but think it means the person had a drop in psa of 50 pct [or more] as result of treatment

Tall_Allen profile image
Tall_Allen in reply toOuttaTime

It is out of context - I was replying to podsart's OP. He was asking a question about my article in which PSA50 is defined.

"They looked at the percent of men whose PSA reduced by 50% or more (PSA50)"

prostatecancer.news/2019/12...

OuttaTime profile image
OuttaTime in reply toTall_Allen

Thank you!

ulfhbg profile image
ulfhbg in reply toOuttaTime

Hi !

I think PSA50 is the percentage of how many that had a PSA decline of 50% or more when treated.

So if for example 20 persons was in the category of high PSMA and 15 of them had a PSA decline of 50 % or more that would be 75 % was in the category PSA50 i would guess

OuttaTime profile image
OuttaTime in reply toulfhbg

Thank you!

Islandboy2021 profile image
Islandboy2021 in reply toTall_Allen

I have been able to get the PSMA scan here in Canada but I don’t think they have the option for a FDG scan. How is the FDG scan done. Should this scan be SOC when you are checking to see if you are PSMA positive before having Pluvicto.

Tall_Allen profile image
Tall_Allen in reply toIslandboy2021

Anyone who offers any kind of PET scan offers an FDG PET.

ulfhbg profile image
ulfhbg in reply toIslandboy2021

When I had my 3 cycles of Lu177 in Finland I had to have a DCFPyL and also a NaF. There was not any discussions in my case to have a FDG, not saying that they don’t use it for some when needed

I had very high SUV Max in both prostate and my affected lymph nodes and that was the check that I was a good candidate for Lutetium treatment.

But like I said, in this case it was how the clinic in Finland I was treated in handled scans to make you were a candidate for Lutetium

On a side note, they also had a SPECT/CT Done 24 hours after each cycle to see radiation activity and any decrease, progress and etc. and they used the DCFPyL and NaF to compare with each SPECT/CT.

Like I said, just a side note on how the finish clinic Docrates is treating with Lutetium and perhaps others that treat with Lutetium uses FDG as well in order to see if you’re a good candidate for Lutetium

Not what you're looking for?

You may also like...

Why Lutetium-177-PSMA treatment sometimes may not help, and may even harm

It's prudent to get an FDG PET/CT at around the same time as the PSMA PET/CT....
Tall_Allen profile image

Lutetium 177 PSMA treatment in Windsor, England

Has anybody been treated in this GenesisCare clinic? We would be so happy to hear your impressions...
blueCello profile image

Limitations of Lutetium-177-PSMA and addressing treatment challenges

For those of us treated with Lutetium-177 or those of us pursuing treatment I found this short...
slpdvmmd profile image

Phase 1 trial shows promising results for fractionated dose of 225Ac-J591 in PCa treatment

The fractionated dosing achieved promising results with 95% of patients experiencing any PSA...
Maxone73 profile image

VISION Trial Results Being Released

The results of the US Phase III Vision Trial of 177Lu-PSMA-617 for mCRPC are finally being released...
MateoBeach profile image

Moderation team

Bethishere profile image
BethishereAdministrator
Number6 profile image
Number6Administrator
Darryl profile image
DarrylPartner

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.